期刊文献+

比索洛尔、地高辛联合治疗老年慢性心力衰竭伴持续性心房颤动的临床研究

Clinical study of bisoprolol combined with digoxin in elderly patients with chronic heart failure complicated with persistent atrial fibrillation
暂未订购
导出
摘要 目的:探究比索洛尔、地高辛联合治疗老年慢性心力衰竭(Chronic heart failure,CHF)伴持续性心房颤动(Atrial fibrillation,AF)临床效果。方法:选取2024年1月至2025年4月永城市人民医院收治的70例老年CHF伴持续性AF患者,随机分成对照组和实验组(n=35),分别口服常规药物联合地高辛0.125 mg(Qd),以及常规药物、地高辛0.0625 mg和比索洛尔0.625 mg(Qd)。治疗1m后,采用心电图机和超声心动图测定两组治疗前后心室率(最大、最小、平均)和心功能指标,包括左室收缩末期内径(Left ventricular end-systolic diameter,LVESD)、左室射血分数(Left ventricular ejection fraction,LVEF)、左室舒张末期内径(Left ventricular end diastolic diameter,LVEDD)。结果:治疗后,对照组和实验组老年CHF伴持续性AF患者的最大、最小、平均心室率、LVEDD和LVESD均显著降低(P<0.05),LVEF显著提高(P<0.05)。实验组老年CHF伴持续性AF患者的最大、最小、平均心室率、LVEDD和LVESD显著低于对照组(P<0.05),LVEF显著高于对照组(P<0.05)。治疗期间,两组不良反应发生率无统计学意义(P>0.05)。结论:比索洛尔、地高辛联合治疗可以有效调节老年CHF伴持续性AF患者心室率,改善心功能,且未增加不良反应发生风险。 Objective:To explore the clinical effect of bisoprolol combined with digoxin in the treatment of elderly patients with chronic heart failure(CHF)and persistent atrial fibrillation(AF).Methods:A total of 70 elderly patients with CHF complicated with persistent AF admitted to Yongcheng People’s Hospital from January 2024 to April 2025 were selected and randomly divided into control group(n=35)and experimental group(n=35),and they received oral administration of conventional drug combined with 0.125 mg of digoxin(once a day)or conventional drug,0.0625 mg of digoxin and 0.625 mg of bisoprolol(once a day)respectively.After 1 month of treatment,the ventricular rates(maximum,minimum,and average)as well as cardiac function indexes,including left ventricular end-systolic diameter(LVESD),left ventricular ejection fraction(LVEF),and left ventricular end-diastolic diameter(LVEDD),were measured by an electrocardiogram machine and echocardiography before and after treatment in the two groups.Results:After treatment,the maximum,minimum,and average ventricular rates,LVEDD,and LVESD of elderly CHF patients with persistent AF in the control group and experimental group were significantly decreased(P<0.05),while LVEF was significantly increased(P<0.05).The maximum,minimum,and average ventricular rates,LVEDD,and LVESD of elderly CHF patients with persistent AF were obviously lower(P<0.05),while the LVEF was significantly higher in the experimental group(P<0.05).During treatment,no statistical significance was found in the incidence of adverse reactions between groups(P>0.05).Conclusion:Bisoprolol combined with digoxin can effectively regulate the ventricular rate and improve cardiac function in elderly CHF patients with persistent AF,without increasing the risk of adverse reactions.
作者 翟平平 Zhai Ping-ping(Department of Cardiovascular Medicine,Yongcheng People's Hospital,Yongcheng 476600,Henan,China)
出处 《四川生理科学杂志》 2025年第12期2765-2767,共3页
关键词 比索洛尔 地高辛 老年 慢性心力衰竭 持续性心房颤动 Bisoprolol Digoxin Elderly Chronic heart failure Persistent atrial fibrillation
  • 相关文献

参考文献11

二级参考文献129

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献4314

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部